376 related articles for article (PubMed ID: 30510105)
1. Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.
Lewis LA; Rice PA; Ram S
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510105
[No Abstract] [Full Text] [Related]
2. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.
Lewis LA; Ngampasutadol J; Wallace R; Reid JE; Vogel U; Ram S
PLoS Pathog; 2010 Jul; 6(7):e1001027. PubMed ID: 20686663
[TBL] [Abstract][Full Text] [Related]
3. The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.
Lewis LA; Carter M; Ram S
J Immunol; 2012 May; 188(10):5063-72. PubMed ID: 22504643
[TBL] [Abstract][Full Text] [Related]
4. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
Giuntini S; Pajon R; Ram S; Granoff DM
Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
[TBL] [Abstract][Full Text] [Related]
5. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
Shaughnessy J; Lewis LA; Jarva H; Ram S
Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
[TBL] [Abstract][Full Text] [Related]
6. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
7. Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against
Shaughnessy J; Lewis LA; Zheng B; Carr C; Bass I; Gulati S; DeOliveira RB; Gose S; Reed GW; Botto M; Rice PA; Ram S
J Immunol; 2018 Nov; 201(9):2700-2709. PubMed ID: 30266769
[TBL] [Abstract][Full Text] [Related]
8. A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
Shaughnessy J; Gulati S; Agarwal S; Unemo M; Ohnishi M; Su XH; Monks BG; Visintin A; Madico G; Lewis LA; Golenbock DT; Reed GW; Rice PA; Ram S
J Immunol; 2016 Feb; 196(4):1732-40. PubMed ID: 26773149
[TBL] [Abstract][Full Text] [Related]
9. Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.
Madico G; Ngampasutadol J; Gulati S; Vogel U; Rice PA; Ram S
J Immunol; 2007 Apr; 178(7):4489-97. PubMed ID: 17372007
[TBL] [Abstract][Full Text] [Related]
10. Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.
Lujan E; Pajon R; Granoff DM
Infect Immun; 2016 Feb; 84(2):452-8. PubMed ID: 26597984
[TBL] [Abstract][Full Text] [Related]
11. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.
Lewis LA; Vu DM; Vasudhev S; Shaughnessy J; Granoff DM; Ram S
mBio; 2013 Oct; 4(5):e00339-13. PubMed ID: 24129254
[TBL] [Abstract][Full Text] [Related]
12. Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant
Shaughnessy J; Tran Y; Zheng B; DeOliveira RB; Gulati S; Song WC; Maclean JM; Wycoff KL; Ram S
Front Immunol; 2020; 11():583305. PubMed ID: 33193396
[TBL] [Abstract][Full Text] [Related]
13. Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?
Ngampasutadol J; Tran C; Gulati S; Blom AM; Jerse EA; Ram S; Rice PA
Vaccine; 2008 Dec; 26 Suppl 8():I62-6. PubMed ID: 19388167
[TBL] [Abstract][Full Text] [Related]
14. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.
Ngampasutadol J; Ram S; Gulati S; Agarwal S; Li C; Visintin A; Monks B; Madico G; Rice PA
J Immunol; 2008 Mar; 180(5):3426-35. PubMed ID: 18292569
[TBL] [Abstract][Full Text] [Related]
15. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.
Lewis LA; Ram S
FEBS Lett; 2020 Aug; 594(16):2670-2694. PubMed ID: 32058583
[TBL] [Abstract][Full Text] [Related]
16.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and molecular conservation of the gonococcal NspA protein.
Plante M; Cadieux N; Rioux CR; Hamel J; Brodeur BR; Martin D
Infect Immun; 1999 Jun; 67(6):2855-61. PubMed ID: 10338491
[TBL] [Abstract][Full Text] [Related]
18. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
Madico G; Welsch JA; Lewis LA; McNaughton A; Perlman DH; Costello CE; Ngampasutadol J; Vogel U; Granoff DM; Ram S
J Immunol; 2006 Jul; 177(1):501-10. PubMed ID: 16785547
[TBL] [Abstract][Full Text] [Related]
19. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.
Ram S; Mackinnon FG; Gulati S; McQuillen DP; Vogel U; Frosch M; Elkins C; Guttormsen HK; Wetzler LM; Oppermann M; Pangburn MK; Rice PA
Mol Immunol; 1999; 36(13-14):915-28. PubMed ID: 10698346
[TBL] [Abstract][Full Text] [Related]
20. Factor H and neisserial pathogenesis.
Welsch JA; Ram S
Vaccine; 2008 Dec; 26 Suppl 8(Suppl 8):I40-5. PubMed ID: 19388163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
